Dendritic cell aggresome-like induced structures are dedicated areas for ubiquitination and storage of newly synthesized defective proteins

Journal of Cell Biology

Volumn 164, Issue 5, 2004, Pages 667-675

  Lelouard, Hugues ^a   Ferrand, Vincent ^a   Marguet, Didier ^a   Bania, Jacek ^a   Camosseto, Voahirana ^a   David, Alexandre ^a   Gatti, Evelina ^a   Pierre, Philippe ^a  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

Antigen processing; DALIS; Dendritic cells; DRiPs; Puromycin

Indexed keywords

ALPHA AMANITIN; ANISOMYCIN; ANTIBIOTIC AGENT; CANAVANINE; CYCLOHEXIMIDE; EMETINE; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 70 INTERACTING PROTEIN; PUROMYCIN; RIBOSOME PROTEIN; T 2 TOXIN; UBIQUITIN ACTIVATING ENZYME E1; UBIQUITIN CONJUGATING ENZYME E2; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIGEN PRESENTATION; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL FATE; CELL MATURATION; CELL SPECIFICITY; CELL STRUCTURE; CYTOSOL; DENDRITIC CELL; DENDRITIC CELL AGGRESOME LIKE INDUCED STRUCTURE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN DEGRADATION; PROTEIN MOTIF; PROTEIN SYNTHESIS; PROTEIN TARGETING; TRANSLATION REGULATION; UBIQUITINATION;

ANIMALS; DENDRITIC CELLS; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; INCLUSION BODIES; MALE; MICE; MICE, INBRED C57BL; MULTIENZYME COMPLEXES; PROTEIN BIOSYNTHESIS; PROTEIN SYNTHESIS INHIBITORS; PROTEINS; PUROMYCIN; RECOMBINANT FUSION PROTEINS; UBIQUITIN; UBIQUITIN-ACTIVATING ENZYMES; UBIQUITIN-CONJUGATING ENZYMES; UBIQUITIN-PROTEIN LIGASES;

EID: 1442358797     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200312073     Document Type: Article

References (29)

1. Banchereau, J., and R.M. Steinman. 1998. Dendritic cells and the control of immunity. Nature. 392:245-252.
2. Chen, Z., and C.M. Pickart. 1990. A 25-kilodalton ubiquitin carrier protein (E2) catalyzes multi-ubiquitin chain synthesis via lysine 48 of ubiquitin. J. Biol. Chem. 265:21835-21842.
3. Chow, A., D. Toomre, W. Garrett, and I. Mellman. 2002. Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature. 418:988-994.
4. Cyr, D.M., J. Hohfeld, and C. Patterson. 2002. Protein quality control: U-box-containing E3 ubiquitin ligases join the fold. Trends Biochem. Sci. 27:368-375.
5. Etlinger, J.D., and A.L. Goldberg. 1980. Control of protein degradation in reticulocytes and reticulocyte extracts by hemin. J. Biol. Chem. 255:4563-4568.
6. Goldberg, A.L. 1972. Degradation of abnormal proteins in Escherichia coli (protein breakdown-protein structure-mistranslation-amino acid analogs-puromycin). Proc. Natl. Acad. Sci. USA. 69:422-426.
7. Heath, C.M., M. Windsor, and T. Wileman. 2001. Aggresomes resemble sites specialized for virus assembly. J. Cell Biol. 153:449-455.
8. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R.M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693-1702.
9. Jiang, J., C.A. Ballinger, Y. Wu, Q. Dai, D.M. Cyr, J. Hohfeld, and C. Patterson. 2001. CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation. J. Biol. Chem. 276:42938-42944.
10. Khan, S., R. de Giuli, G. Schmidtke, M. Bruns, M. Buchmeier, M. van den Broek, and M. Groettrup. 2001. Cutting edge: neosynthesis is required for the presentation of a T cell epitope from a long-lived viral protein. J. Immunol. 167:4801-4804.
11. Kopito, R.R. 2000. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 10:524-530.
12. Lelouard, H., E. Gatti, F. Cappello, O. Gresser, V. Camossetto, and P. Pierre. 2002. Transient aggregation of ubiquitinated proteins during dendritic cell maturation. Nature. 417:177-182.
13. Lizée, G., G. Basha, J. Tiong, J.P. Julien, M. Tian, K.E. Biron, and W.A. Jefferies. 2003. Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain. Nat. Immunol. 4:1065-1073.
14. Meacham, G.C., C. Patterson, W. Zhang, J.M. Younger, and D.M. Cyr. 2001. The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation. Nat. Cell Biol. 3:100-105.
15. Mellman, I., and R.M. Steinman. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell. 106:255-258.
16. Murata, S., Y. Minami, M. Minami, T. Chiba, and K. Tanaka. 2001. CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein. EMBO Rep. 2:1133-1138.
17. Princiotta, M.F., D. Finzi, S.B. Qian, J. Gibbs, S. Schuchmann, F. Buttgereit, J.R. Bennink, and J.W. Yewdell. 2003. Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity. 18:343-354.
18. Qian, S.B., D.E. Ott, U. Schubert, J.R. Bennink, and J.W. Yewdell. 2002. Fusion proteins with COOH-terminal ubiquitin are stable and maintain dual functionality in vivo. J. Biol. Chem. 277:38818-38826.
19. Reits, E.A., J.C. Vos, M. Gromme, and J. Neefjes. 2000. The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature. 404:774-778.
20. Schubert, U., L.C. Anton, J. Gibbs, C.C. Norbury, J.W. Yewdell, and J.R. Bennink. 2000. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature. 404:770-774.
21. Schwab, S.R., K.C. Li, C. Kang, and N. Shastri. 2003. Constitutive display of cryptic translation products by MHC class I molecules. Science. 301:1367-1371.
22. Seufert, W., and S. Jentsch. 1990. Ubiquitin-conjugating enzymes UBC4 and UBC5 mediate selective degradation of short-lived and abnormal proteins. EMBO J. 9:543-550.
23. Vazquez, D. 1974. Inhibitors of protein synthesis. FEBS Lett. 40:S63-S84.
24. Wheatley, D.N., M.R. Giddings, and M.S. Inglis. 1980. Kinetics of degradation of "short-" and "long-lived" proteins in cultured mammalian cells. Cell Biol. Int. Rep. 4:1081-1090.
25. Yewdell, J.W., and J.R. Bennink. 2001. Cut and trim: generating MHC class I peptide ligands. Curr. Opin. Immunol. 13:13-18.
26. Yewdell, J.W., U. Schubert, and J.R. Bennink. 2001. At the crossroads of cell biology and immunology: DRiPs and other sources of peptide ligands for MHC class I molecules. J. Cell Sci. 114:845-851.
27. Yewdell, J.W., E. Reits, and J. Neefjes. 2003. Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat. Rev. Immunol. 3:952-961.
28. Yin, Y., B. Manoury, and R. Fahraeus. 2003. Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1. Science. 301:1371-1374.
29. Zhang, J.X., I. Braakman, K.E. Matlack, and A. Helenius. 1997. Quality control in the secretory pathway: the role of calreticulin, calnexin and BiP in the retention of glycoproteins with C-terminal truncations. Mol. Biol. Cell. 8:1943-1954.